As breast cancer survival improves, cardiotoxic effects of chemotherapy, radiation and newer treatments are receiving more attention. This brief summarizes what survivors should know about risks, practical steps and where care teams can focus follow-up.
Newer targeted radiation techniques aim to reduce heart exposure, but vigilance is still needed for therapy-specific cardiotoxicity.
Patients should report new or subtle symptoms to their oncologist and primary care team and seek coordinated monitoring when appropriate.
# Heart Health After Breast Cancer Treatment
This article by Barbara Jacoby highlights several practical points: historically heart health received little attention during cancer care because the immediate priority was survival. As survivors accumulate, clinicians and patients are examining treatment toxicities more closely and looking for ways to reduce collateral harm.
Chemotherapy agents and some targeted drugs are known to have cardiotoxic potential. Radiation to the chest can also affect heart structures and blood vessels. Jacoby emphasizes that earlier generations of treatment often exposed the heart more, but newer radiation targeting techniques are designed to limit cardiac exposure while still treating the tumor.
Jacoby suggests that as treatments evolve, clinicians need vigilance about long-term harms. Better reporting of side effects and shared databases tracking outcomes could accelerate recognition of cardiotoxicity patterns and inform safer care choices.
Coordination between oncology and cardiology — often called cardio-oncology in practice — helps identify at-risk patients and manage late effects. Survivorship plans should include clear guidance on cardiac monitoring where appropriate.
Longer survival after breast cancer changes what matters beyond eliminating the tumor. Heart health is a real concern for survivors exposed to chemotherapies, radiation and newer therapies. Patients should learn their treatment history, monitor and report symptoms, and work with their care teams to apply structured guidance such as the ABCDE plan. Clinicians should maintain vigilance and improve reporting and coordination to reduce preventable cardiac harm.
Author note: The piece is written by Barbara Jacoby, who highlights both progress in treatment targeting and the need for ongoing attention to treatment-related cardiovascular risk.
Nearly 10 years after Kara Kenan of North Carolina finished treatment for advanced breast cancer, her routine bloodwork revealed an increased level of an enzyme called alkaline phosphatase. Kenan’s primary care doctor didn’t think that was important, so he ordered no further tests. But Kenan, who directs marketing for
People with invasive cancer may be more likely to experience ischemic stroke, according to results of a retrospective cohort study. Risk — which varied considerably by cancer type — appeared particularly elevated in the first few months after diagnosis. This establishes “a critical window” for targeted assessment and i
I know so many women who have battled with breast cancer, and I’m sure you can name a few as well. That’s because 1 in 8 women develop breast cancer in their lifetime, making it the most common cancer in women aside from skin cancer. Keeping your breasts healthy is a number one priority. However, […] The post 6 Ways to
About one in eight women are diagnosed with breast cancer at some point in their lives, according to BreastCancer.org. “Breast cancer is the most common cancer in women worldwide and the most common cause of cancer death worldwide, although survival continues to improve in many countries,” reveals Hope Rugo, MD, medica
From: healthline.com During breast cancer treatment, you may experience several physical and mental changes. How does the body change during overall treatment? Menstrual changes Breast cancer treatments can disrupt hormone production and interrupt your menstrual cycle. This means you may experience: night sweats hot fl
From: healthline.com Fatigue is a common symptom of breast cancer and one of the most common side effects of breast cancer treatment. Studies suggest that 62% to 85%Trusted Source of people undergoing cancer treatment report having cancer-related fatigue. Those with breast cancer may be most affected by fatigue in the
Loading more related stories...
Open the app view to save this story, compare related coverage, and continue from the same source.